%0 Journal Article
%T The role of golimumab in inflammatory arthritis. A review of the
evidence
%A Arthur Kavanaugh
%A Zunera Tahir
%J Archive of "Therapeutic Advances in Musculoskeletal Disease".
%D 2018
%R 10.1177/1759720X18793317
%X Golimumab (GOL) is a tumor necrosis factor inhibitor that is used for various types of inflammatory arthritis such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). This article is a systematic review of the evidence for the efficacy and safety of golimumab in inflammatory arthritides, specifically RA, PsA and AS
%K Golimumab
%K inflammatory arthritides
%K ankylosing spondylitis
%K rheumatoid arthritis
%K psoriatic arthritis
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130092/